• Home
  • /
  • Fund Detail
159847

E Fund CSI Medical Service ETF

159847

E Fund CSI Medical Service ETF

  • Daily NAV and Return
  • Basic Information
  • Portfolio Managers
  • Fee Structure
  • Asset Allocation
  • Historical Daily NAV
  • Fund Distributions
  • Reference Documents
  • ETF PCF
  • Risk Disclaimer
0.4121
NAV(RMB)
-2.62%
Daily Return
Date: 2026-08-19
  • Cumulative Performance
  • Historical Periodic Return
Return: 0.00% Max. Drawdown: 0.00%
Basic Information
Fund Name: E Fund CSI Medical Service ETF
Fund Name (Short name): E Fund CSI Medical Service ETF
Fund Name (Short name on exchange): 医疗ETF易方达
Fund Code: 159847
Listing Exchange: Shenzhen Stock Exchange
Inception Date: 2021-07-08
Fund Manager: E Fund Management Co., Ltd.
Portfolio Managers: Zhan Zhang
Custodian: China Merchants Bank Co., Ltd.
Net Asset Value: As of 18/08/2026: RMB 1,645,750,889.81
Investment Scope:

The investment scope of the Fund includes constituent securities and alternative constituent securities of the Underlying Index, including depositary receipts; stocks other than the constituent securities and alternative constituent securities of the Underlying Index, including stocks listed on the ChiNext Market and the SME Board, as well as other lawfully issued and listed stocks and depositary receipts; bonds, bond repurchase transactions, asset-backed securities, bank deposits, interbank certificates of deposit, money market instruments and financial derivatives, including stock index futures and stock options; and other financial instruments in which investment by the Fund is permitted under applicable laws and regulations or by the China Securities Regulatory Commission.

Where applicable laws and regulations or regulatory authorities permit the Fund to invest in additional instruments in the future, the Fund Manager may include such instruments in the Fund’s investment scope. The investment principles and investment proportions applicable to such instruments shall be implemented in accordance with the relevant provisions of applicable laws and regulations or regulatory authorities.

The Fund will participate in securities lending and financing activities under the refinancing mechanism in accordance with applicable laws and regulations.

Portfolio Allocation: The Fund shall invest no less than 80% of its non-cash assets and no less than 90% of its net asset value in the constituent securities and alternative constituent securities of the Underlying Index, except where such investment is restricted by laws and regulations.
Investment Objective: The Fund aims to closely track the Underlying Index with a view to minimizing tracking deviation and tracking error.
Benchmark: CSI Medical Service Index Return
Portfolio Managers
  • Current Portfolio Managers
  • Former Portfolio Managers List
Zhan Zhang
Former Portfolio Manager Start Date End Date
Zhan Zhang 2021-07-08 --
Fee Structure
Fund Sales-related Fees
1. When investors subscribe for or redeem Fund units on exchange, the securities companies acting as agents may charge a commission of up to 0.5%, inclusive of the relevant fees charged by the stock exchange, the registration and settlement institution and other relevant parties. 2. On-exchange trading fees shall be subject to the actual fees charged by the securities companies.
Management Fee and Custody Fee
Management Fee 0.15%
Custody Fee 0.05%
Note: For details of the rules governing the charging of the Fund’s management fee, custody fee and sales service fee, please refer to the CN prospectus and other legal documents.
Asset Allocation
Select Date:

--

  • 03-31
  • 06-30
  • 09-30
  • 12-31
Search
Type of asset Amount(RMB) % of Total Asset of the Fund
Equity Investment 1,523,021,086.10 99.51%
Bank Deposit and Settlement Reserve 3,803,084.42 0.25%
Others 3,669,850.37 0.24%
Total 1,530,494,020.89 100.00%
Total Asset: 0 !
Net Asset Value (NAV) = Total Asset Value - Total Liability. There could be difference between total asset value and net asset value due to the possible liability (e,g, payable). All numbers are calculated on fund level.
Top 10 Stock Holding(53.77%)
Stock Name Stock Code Number of Shares % of NAV
WuXi AppTec Co., Ltd. 603259 1,510,281 12.32%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 300760 1,015,078 9.03%
Shanghai United Imaging Healthcare Co., Ltd. 688271 1,009,552 6.70%
Aier Eye Hospital Group Co.,Ltd. 300015 9,514,443 5.15%
Asymchem Laboratories (Tianjin) Co., Ltd. 002821 407,950 4.33%
Pharmaron Beijing Co., Ltd. 300759 2,111,464 4.00%
iRay Group 688301 423,790 3.44%
Hangzhou Tigermed Consulting Co., Ltd 300347 1,054,271 3.32%
Andon Health Co., Ltd. 002432 665,907 3.08%
Intco Medical Technology Co.,Ltd 300677 935,863 2.40%
Fund Distributions
~
Search
Export
Record Date Reference Date Distribution per
Unit (RMB)
Distribution Payment Date
No Data
Reference Documents
~
Subscription/Redemption List
Search
Download File
No on-exchange subscription/redemption list information is currently available
Risk Disclaimer

Dear Investors,

Please be advised that investment inherently carries risks, and it is recommended to allocate capital prudently. The mutual fund (hereinafter referred to as the "Fund") is structured as a long-term investment vehicle, primarily aimed at diversifying investments and mitigating the risks associated with individual security acquisitions. Unlike financial mechanisms offering guaranteed returns, such as savings accounts, subscribing to a mutual fund entails participating in the Fund's portfolio returns relative to your investment share, as well as bearing any associated losses.

In compliance with current regulatory requirements, distributors must classify investors' categories, assess investors' risk tolerance, and determine the risk level of the funds, providing appropriate matching advice. Note that discrepancies may exist between the Fund's risk descriptions in its legal documentation and the risk evaluations made by the distribution entity. Therefore, before making any investment decisions, investors are urged to carefully read and understand the product’s legal documents, including the Fund Contract, Prospectus, Summary of Fund Information, and Risk Disclosure Statement. This will ensure a thorough understanding of the risk-return dynamics and intrinsic attributes of the Fund. Investors should meticulously evaluate the Fund’s various risk factors and, considering their investment objectives, timelines, experience, and financial standing, conduct a comprehensive assessment of their risk tolerance. This will allow for informed and prudent investment decisions based on an intrinsic understanding of the product and suitability assessments provided by the distributors.

Pursuant to relevant legal frameworks, E Fund Management Co., Ltd., as the Fund Manager, hereby disseminates the following risk disclosure:

I. Depending on their investment objectives, the Fund is classified into various categories, including equity funds, balanced funds, bond funds, money market funds, fund-of-funds (FoF), and commodity funds. Each category offers differing expectations of return and associated risks. Generally, higher expected returns are often accompanied by higher risks.

II. Investors should achieve a robust understanding of the differences between systematic investment plans and traditional savings methods such as fixed deposits. Systematic investment plans are designed to promote long-term investment and average investment costs, but they do not insulate investors from market risks or guarantee returns. Thus, they should not be viewed as direct substitutes for traditional savings methods.

III. During its investment operations, the Fund may encounter various risks, including market risk, liquidity risk, management risk, tax risk, technological risk, and compliance risk.

IV. Potential investment risks associated with the Fund include market risks, management risks, technical risks, risks specific to the Fund, risks that the descriptions of the Fund's risk characteristics in the legal documents of the Fund may not be consistent with the risk ratings provided by the Distributors and other risks. Risks specific to the Fund include risks of investing in index, risks of the Underlying Index, risks of tracking deviation and tracking error, risks of tracking error control failing to reach the agreed target, risks of deviation of the fund trading price from the Net Asset Value per Unit, risks of decision-making with reference to IOPV and IOPV miscalculation, risks of suspended trading of constituent stocks, risks of failed Creation by Investors, risks of failed Redemption by Investors, risks of different forms of Creation and Redemption consideration for Exchange-traded and OTC Fund units, risks of realizing the Redemption Consideration for Exchanged-traded Fund units, risks of arbitraging, risks of error in the Portfolio Composition File, risks of liquidity, risks of delisting, risks of third-party services, risks of investing in depositary receipts, risks of pooled Creation, etc.

V. The Fund Manager commits to managing and utilizing the Fund's assets with diligence, integrity, and honesty. However, the profitability or a minimum return on the Fund cannot be guaranteed. The Fund's historical performance and net asset values are not indicative of future performance. The performance of other funds managed by E Fund Management Co., Ltd. is not a guarantee for the performance of this Fund. Investors are reminded to adhere to the principle of "caveat emptor" when investing in funds and to bear the associated risks of fluctuations in the Fund’s operations and net asset values when making investment decisions. Neither the Fund Manager, the custodian, the distributors, nor affiliated entities make any commitments or guarantees regarding the Fund’s returns.

VI. The registration of the Fund with the China Securities Regulatory Commission (CSRC) does not imply any substantive judgment or guarantee of its value or returns, nor does it indicate that the Fund is risk-free. The Fund Manager manages and utilizes the Fund's assets adhering to principles of diligence, honesty, and credibility, but cannot guarantee profitability or a minimum return. Investors who purchase fund shares in accordance with the Fund Contract become unit holders and parties to the Fund Contract. Any disputes arising from or in relation to the Fund Contract should initially be resolved through negotiation and mediation. If negotiation fails, arbitration will be the final means of dispute resolution, as detailed in the Fund Contract. The Fund Contract, Prospectus, and Information Summary of this Fund have been publicly disclosed on the CSRC Fund Electronic Disclosure Website at http://eid.csrc.gov.cn/fund and on the Fund Manager's website at http://www.efunds.com.cn.

VII. Investors are advised to purchase or redeem Fund shares through the Fund Manager or other authorized institutions with fund sales qualifications. A list of such institutions can be found on the Fund Manager's website.